カテゴリ： IT/電子, MarketsandMarkets, 世界

アドバンスディレクティブのグローバル市場予測（～2028）：ソフトウェア、サービス

■ 英語タイトル：Advance Directives Market by Component (Software, Services), Demographics (Elderly Population (65 yrs & above), Middle Aged (40-64 yrs), Young Adults (18-39 yrs)), End User (B2B (Providers, Payers), B2C), & Region - Global Forecast to 2028

調査会社MarketsandMarkets社が発行したリサーチレポート（データ管理コード：HIT8782-23）■ 発行会社/調査会社：MarketsandMarkets
■ 商品コード：HIT8782-23
■ 発行日：2023年9月13日
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：145
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥1,010,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,238,800見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[アドバンスディレクティブのグローバル市場予測（～2028）：ソフトウェア、サービス]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

"アドバンスディレクティブ市場は2023年の1,229億米ドルから2028年には2,911億米ドルに達すると予測され、予測期間中の年平均成長率は18.8％"
アドバンスディレクティブの増加、患者のケアと自律性を強化するための政府の取り組みや規制は、予測期間中に市場に有利な機会を提供します。

"2022年、アドバンスディレクティブ市場はアドバンスディレクティブサービス分野が構成要素別で大きなシェアを占める"
2022年、アドバンスディレクティブサービス分野がアドバンスディレクティブ市場の実質的なシェアを占めました。事前医療計画の重要性に対する認識が高まり、医療政策や規制は、不要な介入や医療費を削減し、患者中心のケアを確保するという点で、アドバンスディレクティブの利点を認識するようになっています。このような認識により、医療システムはこれらのサービスを標準的な業務に統合するようになり、このセグメントの急成長を牽引しています。

"2022年のアドバンスディレクティブ市場、エンドユーザー別では医療提供者セグメントがかなりのシェアを占める"
2022年のアドバンスディレクティブ市場では、医療提供者セグメントがかなりのシェアを占めています。医療制度が患者中心のケアと個別治療を優先する中、医療提供者は終末期の嗜好、治療オプション、医療介入に関する会話を開始する上で重要な役割を担っています。医療提供者の専門知識と患者との信頼関係は、事前ケア計画にまつわるデリケートな議論を効果的に進める上で重要な役割を果たします。さらに、医療提供者が電子カルテ（EHR）やデジタルツールを導入することで、AD文書の文書化と普及が合理化され、患者の希望へのアクセス性と実行性が高まっています。その結果、医療提供者セグメントはアドバンスディレクティブ市場において顕著な成長促進要因となっています。

"予測期間中、アジアが大幅な成長率を記録"
アジア市場は、進化する社会的態度、医療アクセスの増加、患者の自主性に対する意識の高まりを反映した要因が重なり、予測期間中に高いCAGRで成長すると予測されています。同地域では高齢化や慢性疾患の増加など人口動態の変化が進んでおり、終末期医療の重要性に対する認識が高まっています。政府や医療機関は、死や終末期医療に関する議論をめぐる文化的タブーを克服し、より開かれた対話の促進に取り組んでいます。さらに、医療インフラの進歩や患者中心のケア構想の台頭により、ADリソースへのアクセスが容易になっています。医療上の意思決定について患者が発言権を持ちたいという願望と、医療と個人の嗜好を一致させる取り組みが相まって、アジアの予測年数におけるADの大幅な成長を後押ししています。

主な参入企業の内訳は以下の通りです：
- 企業タイプ別：ティア1：45％、ティア2：30％、ティア3：25％
- 役職別-Cレベル：42％、ディレクターレベル：31％、その他：27％
- 地域別-北米：32％、ヨーロッパ：32％、アジア太平洋：26％、中東・アフリカ：5％、中南米：5％

アドバンスディレクティブソリューション市場の主要企業：
アドバンスディレクティブ市場で事業を展開する主要企業には、ADvault, Inc.(US), VyncaCare (US), WiserCare Inc.(US), Sharp HealthCare(US), ACP Decisions (a DBA of Nous Foundation, Inc.) (US), Iris Healthcare(Aledade, Inc.) (US), Bronson Health Care Group, Inc. (US), Koda Health(US), ThroughCare, Inc.(US), Vital Decisions LLC (US), Affirm Health Inc. (US), MIDEO(US), New Century Health (US), Thanacare(US), Island Health(Canada), Honor My Decisions LLC (US)が含まれます。

調査範囲：
この調査レポートは、アドバンスディレクティブ市場を分析し、構成要素、人口統計学、エンドユーザー、地域に基づいて、様々な市場セグメントの市場規模と今後の成長可能性を推定することを目的としています。また、同市場で事業を展開する主要企業の競争分析も行い、企業プロフィール、製品提供、最近の開発状況、主要市場戦略などを掲載しています。

レポートを購入する理由：
本レポートは、既存企業だけでなく、新規参入企業や中小企業にとっても、市場の動向を把握する上で有益であり、ひいては市場シェアを拡大する上で役立ちます。本レポートを購入された企業は、以下の戦略の1つまたは組み合わせを使用して、市場での地位を強化することができます。

本レポートは以下の洞察を提供します：
アドバンスディレクティブ市場の成長に影響を与える主な促進要因（先進国および新興テクノロジー導入におけるアドバンスディレクティブ投資の増加、個別化ケアに対する需要の高まり、事前ケア計画に対する資金調達と投資の増加）、阻害要因（認識と教育の欠如、コミュニケーションの障壁）、機会（技術的進歩とデジタルソリューション、政策支援と法的枠組み）、課題（断片化した医療制度、指示的な協力とコミュニケーションの欠如）の分析を行っています。
製品開発／イノベーション：アドバンスディレクティブ市場における今後の技術、研究開発活動、新製品・サービス発表に関する詳細な洞察を掲載しています。
市場開発：有利な新興市場、コンポーネント、人口統計、エンドユーザー、地域に関する包括的な情報を提供します。
市場の多様化：事前指示市場における製品ポートフォリオ、成長地域、最近の開発、投資に関する詳細情報を提供します。
競合評価：ADvault, Inc.(US), VyncaCare (US), WiserCare Inc.(US), Sharp HealthCare(US), ACP Decisions (a DBA of Nous Foundation, Inc.) (US), Iris Healthcare(Aledade, Inc.) (US)などの事前指示市場における主要企業の市場シェア、成長戦略、製品提供、能力を詳細に評価します。

1.イントロダクション
2.調査方法
3.エグゼクティブサマリー
4.プレミアムインサイト
5.市場概要
6.アドバンスディレクティブの市場分析：コンポーネント別
7.アドバンスディレクティブの市場分析：デモグラフィック別
8.アドバンスディレクティブの市場分析：エンドユーザー別
9.アドバンスディレクティブの市場分析：地域別
10.競争状況
11.企業情報
12.付録

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 INTRODUCTION 22
1.1 STUDY OBJECTIVES 22
1.2 MARKET DEFINITION 22
1.2.1 INCLUSIONS AND EXCLUSIONS 22
1.3 MARKET SCOPE 23
1.3.1 MARKETS COVERED 23
FIGURE 1 ADVANCE CARE PLANNING SOLUTIONS MARKET SEGMENTATION 23
1.3.2 YEARS CONSIDERED 23
1.3.3 CURRENCY CONSIDERED 24
1.4 STAKEHOLDERS 24
1.5 LIMITATIONS 24
1.6 RECESSION IMPACT 24
2 RESEARCH METHODOLOGY 25
2.1 RESEARCH DATA 25
FIGURE 2 RESEARCH DESIGN 25
2.1.1 SECONDARY DATA 26
2.1.1.1 Key data from secondary sources 26
2.1.2 PRIMARY DATA 27
FIGURE 3 PRIMARY SOURCES 27
2.1.2.1 Key data from primary sources 28
2.1.2.2 Insights from primary experts 29
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 29
2.2 MARKET SIZE ESTIMATION 30
2.2.1 APPROACH 1: BOTTOM-UP APPROACH (DEMAND-SIDE ANALYSIS) 30
FIGURE 5 BOTTOM-UP APPROACH (DEMAND SIDE ANALYSIS) 30
2.2.2 APPROACH 2: TOP-DOWN OF PARENT MARKET ASSESSMENT 31
2.2.3 APPROACH 3: PRIMARY INTERVIEWS 31
2.2.4 APPROACH 4: TOP-DOWN APPROACH 31
FIGURE 6 TOP-DOWN APPROACH 31
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, OPPORTUNITIES, AND CHALLENGES 32
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 33
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 34
FIGURE 9 DATA TRIANGULATION METHODOLOGY 34
2.4 MARKET SHARE ESTIMATION 35
2.5 STUDY ASSUMPTIONS 35
2.6 RESEARCH LIMITATIONS 35
2.6.1 METHODOLOGY-RELATED LIMITATIONS 35
2.7 RISK ASSESSMENT 36
TABLE 1 RISK ASSESSMENT: ADVANCE CARE PLANNING SOLUTIONS MARKET 36
2.8 ADVANCE CARE PLANNING SOLUTIONS MARKET: RECESSION IMPACT ANALYSIS 36
3 EXECUTIVE SUMMARY 37
FIGURE 10 ADVANCE CARE PLANNING SOLUTIONS, BY COMPONENT, 2023 VS. 2028 (USD MILLION) 37
FIGURE 11 ADVANCE CARE PLANNING SOLUTIONS, BY AGE GROUP, 2023 VS. 2028 (USD MILLION) 38
FIGURE 12 ADVANCE CARE PLANNING SOLUTIONS, BY END USER, 2023 VS. 2028 (USD MILLION) 38
FIGURE 13 ADVANCE CARE PLANNING SOLUTIONS MARKET: GEOGRAPHICAL SNAPSHOT 39
4 PREMIUM INSIGHTS 40
4.1 ADVANCE CARE PLANNING SOLUTIONS MARKET OVERVIEW 40
FIGURE 14 TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET GROWTH 40
4.2 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER AND COUNTRY (2022) 41
FIGURE 15 JAPAN TO DOMINATE ASIA PACIFIC MARKET IN 2022 41
4.3 REGIONAL MIX: ADVANCE CARE PLANNING SOLUTIONS MARKET (2021–2028) 41
FIGURE 16 ASIA TO REGISTER HIGHEST GROWTH RATE OVER 2023–2028 41
4.4 ADVANCE CARE PLANNING SOLUTIONS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES, 2023 VS. 2028 42
FIGURE 17 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH OVER STUDY PERIOD 42
5 MARKET OVERVIEW 43
5.1 INTRODUCTION 43
5.2 MARKET DYNAMICS 43
FIGURE 18 ADVANCE CARE PLANNING SOLUTIONS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES 43
TABLE 2 MARKET DYNAMICS: ADVANCE CARE PLANNING SOLUTIONS MARKET 44
5.2.1 DRIVERS 44
5.2.1.1 Rising investments in ACP 44
5.2.1.2 Government initiatives and regulations to enhance patient care and autonomy 45
5.2.1.3 Cost-cutting potential of ACP solutions 45
5.2.1.4 Rising geriatric population and chronic disease prevalence 46
5.2.2 OPPORTUNITIES 46
5.2.2.1 Technological advancements and digital solutions 46
5.2.2.2 Policy support and legislative frameworks 47
5.2.2.3 Personalized solutions 47
5.2.3 CHALLENGES 47
5.2.3.1 Fragmented healthcare systems and integration & cultural challenges 47
5.2.3.2 Complexity of healthcare systems 48
5.2.3.3 Lack of interdisciplinary collaboration and communication 48
5.3 INDUSTRY TRENDS 49
5.3.1 DIGITAL TRANSFORMATION OF ACP 49
5.3.2 DATA-DRIVEN INSIGHTS: TRANSFORMING ACP 49
5.3.3 ENHANCING PATIENT ENGAGEMENT AND PERSONALIZED CARE IN ACP 49
5.4 TECHNOLOGY ANALYSIS 50
5.4.1 TECHNOLOGY STACK 50
5.4.1.1 EHRs and digital platforms 50
5.4.1.2 Telemedicine/Telehealth 50
5.4.1.3 Digital access 50
5.4.1.4 Patient decision support 51
5.4.1.5 Blockchain technology 51
5.5 PORTER’S FIVE FORCES ANALYSIS 52
TABLE 3 ADVANCE CARE PLANNING SOLUTIONS MARKET: PORTER’S FIVE FORCES ANALYSIS 52
5.5.1 INTENSITY OF COMPETITIVE RIVALRY 52
5.5.2 BARGAINING POWER OF SUPPLIERS 52
5.5.3 BARGAINING POWER OF BUYERS 52
5.5.4 THREAT OF NEW ENTRANTS 53
5.5.5 THREAT OF SUBSTITUTES 53
5.6 REGULATORY LANDSCAPE 53
5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 53
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 53
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 54
TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 56
TABLE 7 ADVANCE CARE PLANNING SOLUTIONS MARKET: REGULATORY STANDARDS 57
5.7 VALUE CHAIN ANALYSIS 58
FIGURE 19 ADVANCE CARE PLANNING SOLUTIONS MARKET: VALUE CHAIN ANALYSIS (2022) 58
5.7.1 RESEARCH AND PRODUCT DEVELOPMENT 58
5.7.2 SERVICE DELIVERY AND IMPLEMENTATION 58
5.7.3 END-USER INDUSTRIES AND AFTERSALES SERVICE PROVIDERS 58
5.8 ECOSYSTEM/MARKET MAP 59
FIGURE 20 ADVANCE CARE PLANNING SOLUTIONS MARKET: ECOSYSTEM ANALYSIS 59
5.9 PATENT ANALYSIS 59
FIGURE 21 NUMBER OF PATENTS PUBLISHED, JANUARY 2013 TO JULY 2023 59
FIGURE 22 ADVANCE CARE PLANNING SOLUTIONS: TOP PATENT OWNERS 60
TABLE 8 KEY PATENTS IN ADVANCE CARE PLANNING SOLUTIONS MARKET 60
5.10 ADJACENT MARKET ANALYSIS 61
FIGURE 23 CARE MANAGEMENT SOLUTIONS MARKET: MARKET OVERVIEW 62
FIGURE 24 POPULATION HEALTH MANAGEMENT MARKET: MARKET OVERVIEW 62
5.11 CASE STUDY ANALYSIS 63
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 64
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 64
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 64
TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 64
5.12.2 BUYING CRITERIA 64
FIGURE 26 KEY BUYING CRITERIA FOR ACP SOLUTION COMPONENTS 64
TABLE 10 KEY BUYING CRITERIA FOR ACP SOLUTION COMPONENTS 65
5.13 KEY CONFERENCES AND EVENTS IN 2023–2024 65
TABLE 11 ADVANCE CARE PLANNING SOLUTIONS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2023–2024 65
5.14 TRENDS/DISRUPTIONS IMPACTING BUYERS 66
FIGURE 27 ADVANCE CARE PLANNING SOLUTIONS: TRENDS/DISRUPTIONS IMPACTING BUYERS 66
6 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT 67
6.1 INTRODUCTION 68
TABLE 12 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 68
6.2 SOFTWARE 68
6.2.1 SOFTWARE TO GROW AT HIGHEST CAGR OVER FORECAST PERIOD 68
TABLE 13 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION) 69
6.3 SERVICES 69
6.3.1 GROWING AWARENESS OF ACP TO DRIVE DEMAND FOR SERVICES 69
TABLE 14 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 70
7 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP 71
7.1 INTRODUCTION 72
TABLE 15 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 72
7.2 ELDERLY POPULATION 72
7.2.1 RISING CHRONIC DISEASE PREVALENCE IN OLDER ADULTS TO DRIVE MARKET 72
TABLE 16 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR ELDERLY POPULATION, BY COUNTRY, 2021–2028 (USD MILLION) 73
7.3 MIDDLE-AGED ADULTS 73
7.3.1 GROWING AWARENESS TO BOOST DEMAND FOR ACP 73
TABLE 17 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR MIDDLE-AGED ADULTS, BY COUNTRY, 2021–2028 (USD MILLION) 74
7.4 YOUNG ADULTS 74
7.4.1 RISING RELEVANCE OF ACP AMONG YOUNG ADULTS TO DRIVE DEMAND 74
TABLE 18 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR YOUNG ADULTS, BY COUNTRY, 2021–2028 (USD MILLION) 75
8 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER 76
8.1 INTRODUCTION 77
TABLE 19 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION) 77
8.2 B2B 77
8.2.1 B2B SEGMENT TO DOMINATE END-USER MARKET 77
TABLE 20 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 78
TABLE 21 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 78
TABLE 22 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 23 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 79
8.3 B2C 80
8.3.1 B2C END USERS TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD 80
TABLE 24 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 25 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR BY B2C END USERS, BY TYPE, 2021–2028 (USD MILLION) 81
TABLE 26 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR CAREGIVERS, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 27 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 82
9 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY REGION 83
9.1 INTRODUCTION 84
TABLE 28 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 84
9.2 NORTH AMERICA 84
FIGURE 28 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET SNAPSHOT 85
TABLE 29 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 30 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 86
TABLE 31 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 86
TABLE 32 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION) 86
TABLE 33 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 87
TABLE 34 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION) 87
9.2.1 US 87
9.2.1.1 US to hold largest share of North American market 87
TABLE 35 US: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 88
TABLE 36 US: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 88
TABLE 37 US: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION) 88
TABLE 38 US: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 89
TABLE 39 US: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION) 89
9.2.2 CANADA 89
9.2.2.1 Favorable government initiatives to drive market 89
TABLE 40 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 90
TABLE 41 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 90
TABLE 42 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION) 90
TABLE 43 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 91
TABLE 44 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION) 91
9.3 EUROPE 91
TABLE 45 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 46 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 92
TABLE 47 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 92
TABLE 48 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION) 93
TABLE 49 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 93
TABLE 50 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION) 93
9.3.1 GERMANY 94
9.3.1.1 Germany to hold largest share of European market 94
TABLE 51 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 94
TABLE 52 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 94
TABLE 53 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION) 95
TABLE 54 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 95
TABLE 55 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION) 95
9.3.2 UK 96
9.3.2.1 Rising awareness and emphasis on ACP to support market growth 96
TABLE 56 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 96
TABLE 57 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 96
TABLE 58 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION) 97
TABLE 59 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 97
TABLE 60 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION) 97
9.3.3 REST OF EUROPE 98
TABLE 61 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 98
TABLE 62 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 99
TABLE 63 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION) 99
TABLE 64 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 99
TABLE 65 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION) 100
9.4 ASIA PACIFIC 100
FIGURE 29 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET SNAPSHOT 101
TABLE 66 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 67 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 102
TABLE 68 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 102
TABLE 69 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION) 103
TABLE 70 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 103
TABLE 71 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION) 103
9.4.1 JAPAN 104
9.4.1.1 Growing cancer incidence and rising awareness to drive market 104
TABLE 72 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 104
TABLE 73 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 104
TABLE 74 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION) 105
TABLE 75 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 105
TABLE 76 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION) 105
9.4.2 CHINA 106
9.4.2.1 China to register highest CAGR over forecast period 106
TABLE 77 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 106
TABLE 78 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 106
TABLE 79 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION) 107
TABLE 80 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 107
TABLE 81 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION) 107
9.4.3 REST OF ASIA PACIFIC 108
TABLE 82 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 108
TABLE 83 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 108
TABLE 84 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION) 109
TABLE 85 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 109
TABLE 86 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION) 109
9.5 REST OF THE WORLD 110
TABLE 87 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 110
TABLE 88 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 110
TABLE 89 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION) 111
TABLE 90 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 111
TABLE 91 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION) 111
10 COMPETITIVE LANDSCAPE 112
10.1 INTRODUCTION 112
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 112
FIGURE 30 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS BETWEEN JANUARY 2020 AND AUGUST 2023 113
10.3 MARKET RANKING ANALYSIS 114
FIGURE 31 ADVANCE CARE PLANNING SOLUTIONS MARKET RANKING ANALYSIS, BY PLAYER, 2022 114
10.4 COMPANY EVALUATION MATRIX, 2022 114
10.4.1 STARS 114
10.4.2 EMERGING LEADERS 114
10.4.3 PERVASIVE PLAYERS 115
10.4.4 PARTICIPANTS 115
FIGURE 32 ADVANCE CARE PLANNING: COMPANY EVALUATION MATRIX (2022) 115
10.5 COMPETITIVE BENCHMARKING 116
TABLE 92 ADVANCE CARE PLANNING SOLUTIONS: COMPANY FOOTPRINT ANALYSIS 116
TABLE 93 COMPONENT FOOTPRINT ANALYSIS (16 COMPANIES) 116
TABLE 94 END-USER FOOTPRINT ANALYSIS (16 COMPANIES) 117
10.6 KEY PLAYER ANALYSIS 118
10.7 COMPETITIVE SCENARIO AND TRENDS 119
10.7.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 119
TABLE 95 PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2020–AUGUST 2023 119
10.7.2 DEALS 119
TABLE 96 DEALS, JANUARY 2020–AUGUST 2023 119
10.7.3 OTHER DEVELOPMENTS 120
TABLE 97 OTHER DEVELOPMENTS, JANUARY 2020– AUGUST 2023 120
11 COMPANY PROFILES 121
11.1 KEY PLAYERS 121
(Company overview, Products & Services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices, and Weaknesses and competitive threats)*
11.1.1 ADVAULT, INC. 121
TABLE 98 ADVAULT, INC.: BUSINESS OVERVIEW 121
11.1.2 VYNCACARE 124
TABLE 99 VYNCACARE: BUSINESS OVERVIEW 124
11.1.3 WISERCARE, INC. 126
TABLE 100 WISERCARE, INC.: BUSINESS OVERVIEW 126
11.1.4 IRIS 128
TABLE 101 IRIS: BUSINESS OVERVIEW 128
11.1.5 KODA HEALTH 130
TABLE 102 KODA HEALTH: BUSINESS OVERVIEW 130
11.1.6 THOROUGHCARE, INC. 131
TABLE 103 THOROUGHCARE, INC.: BUSINESS OVERVIEW 131
11.1.7 VITAL DECISIONS LLC 132
TABLE 104 VITAL DECISIONS LLC: BUSINESS OVERVIEW 132
11.1.8 AFFIRM HEALTH, INC. 133
TABLE 105 AFFIRM HEALTH, INC.: BUSINESS OVERVIEW 133
11.1.9 MIDEO 134
TABLE 106 MIDEO: BUSINESS OVERVIEW 134
11.1.10 NEW CENTURY HEALTH 135
TABLE 107 NEW CENTURY HEALTH: BUSINESS OVERVIEW 135
11.1.11 THANACARE 136
TABLE 108 THANACARE: BUSINESS OVERVIEW 136
11.1.12 HONOR MY DECISIONS LLC 137
TABLE 109 HONOR MY DECISIONS: BUSINESS OVERVIEW 137
11.2 NON-PROFIT ORGANIZATIONS 138
11.2.1 SHARP HEALTHCARE 138
TABLE 110 SHARP HEALTHCARE: BUSINESS OVERVIEW 138
11.2.2 ACP DECISIONS 139
TABLE 111 ACP DECISIONS: BUSINESS OVERVIEW 139
11.2.3 BRONSON HEALTHCARE 140
TABLE 112 BRONSON HEALTHCARE: BUSINESS OVERVIEW 140
11.2.4 ISLAND HEALTH 141
TABLE 113 ISLAND HEALTH: BUSINESS OVERVIEW 141
11.2.5 MUNSON HEALTHCARE 142
TABLE 114 MUNSON HEALTHCARE: BUSINESS OVERVIEW 142
*Details on Company overview, Products & Services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX 143
12.1 DISCUSSION GUIDE 143
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 146
12.3 CUSTOMIZATION OPTIONS 148
12.4 RELATED REPORTS 148
12.5 AUTHOR DETAILS 149



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ゲノミクスにおける人工知能（AI）のグローバル市場予測（～2028）：ソフトウェア、サービス
  • クラウド系量子コンピューティングのグローバル市場予測（～2028）：ソフトウェア、サービス
  • RNA解析のグローバル市場予測（～2028）：試薬、機器、ソフトウェア、サービス
  • ゲノミクスのグローバル市場予測（～2028）：消耗品、サービス、機器・システム・ソフトウェア
  • 監視ツールのグローバル市場予測（～2028）：ソフトウェア（展開別）、サービス
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(HIT8782-23 )"アドバンスディレクティブのグローバル市場予測（～2028）：ソフトウェア、サービス" (英文：Advance Directives Market by Component (Software, Services), Demographics (Elderly Population (65 yrs & above), Middle Aged (40-64 yrs), Young Adults (18-39 yrs)), End User (B2B (Providers, Payers), B2C), & Region - Global Forecast to 2028)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。